Clinical and Translational Medicine
Clinical and Translational Medicine (CTM) is a peer-review open access journal published under the brand SpringerOpen and aims to play an important and recognized role in reporting knowledge that contributes towards the understanding of molecular mechanisms of disease. CTM also aims to foster a predictive, preventive, personalized and practical approach towards precision medicine, leading to improved patient prognosis. The journal provides a forum for exchange of ideas between basic and clinical scientists on molecular and cellular mechanisms of disease and potential therapies.
Clinical and Translational Medicine is a truly international, peer-reviewed, and open access journal devoted to the publication of articles on scientific and clinical investigations which will promote and accelerate the translation of preclinical research to a clinical application and the communication between basic and clinical scientists. CTM emphasizes clinical potential and application of new biotechnologies, biomaterials, bioengineering, disease-specific biomarkers, cellular and molecular medicine, omics science, bioinformatics, applied immunology, molecular imaging, drug discovery and development, and regulation and health policy. CTM will specially focus on the bench to bedside approach, favouring studies and clinical observations which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine. CTM welcomes submissions from companies, clinicians, scientists and policy makers.
3 Volumes 3 Issues 63 Articles available from 2012 - 2014Browse Volumes & Issues
Paul W Sylvester (September 2014)
- Journal Title
- Clinical and Translational Medicine
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Volume 1 / 2012 - Volume 3 / 2014
- Online ISSN
- Springer Berlin Heidelberg
- Additional Links
To view the rest of this content please follow the download PDF link above.